Precision Dose initiated the recall in response to Amneal’s recall, which included lots repackaged by Precision Dose.
The drugmaker found levels of N-Nitrosodimethylamine in the product higher than the FDA accepts.
Consumers, distributors and retailers with the affected lots should stop use and call Precision dose to obtain a return packet.
Precision Dose has not received any adverse event reports related to the recall.
Read the full news release here.
More articles on pharmacy:
AHA, CVS Health backed secretive anti-pharma group
EpiPen, Humira among drugs Warren wants to regulate
31 drugmakers at high risk for bankruptcy in 2020
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
